Ortin Global — 360° view

Ortin Global, a company in the Pharmaceuticals industry, reported revenue of ₹0.04 crore and a net loss of ₹0.27 crore for the September 2026 quarter.

Ortin Global (NSE: ORTINGLOBE) closed at ₹12.37 on 20 Nov 2026, up 3.1% over the past year. Its market capitalisation is ₹10 crore.

Share price
₹12.37 (20 Nov 2026)
Market cap
₹10 Cr (20 Nov 2026)
Revenue
₹0 Cr (September 2026 quarter)
Net profit
₹-0 Cr (September 2026 quarter)
ROCE
-33.9% (FY26)
ROE
-48.4% (FY26)
Book value
₹0.77 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹21.30 / ₹11.33 (20 Nov 2026)
1-year return
3.1% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: ORTINGLOBE

Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.